Sponsor Pipeline

Risen (Suzhou) Pharma Tech Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07207070 A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy… Breast Cancer Recruiting
Phase 2
NCT07579884 To Evaluate the Safety and Efficacy of RP902 Tablets Mild Cognitive Impairment (MCI) Not Yet Recruiting
Phase 1/2
NCT06208410 A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With… Advanced Solid Tumors Recruiting
Disease Areas
Breast Cancer (1)
Get alerts when Risen (Suzhou) Pharma Tech Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free